Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Clinical Trial to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Multiple Myeloma
Beijing Immunochina Medical Science & Technology Co., Ltd.
· 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
multiple-myeloma
multiple myeloma, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
#1033723
Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma
#1033716
Acupuncture for Heel Pain Syndrome
#1033717
A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
#1033719
Results of Endoscopic Sinus Surgery in Management of Ophthalmological Complications of Chronic Rhino Sinusitis
#1033721
Record
· ID 883306
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.